Suppr超能文献

用于胃肠道内镜黏膜切除术和内镜黏膜下剥离术的黏膜下注射溶液。

Submucosal injection solution for gastrointestinal tract endoscopic mucosal resection and endoscopic submucosal dissection.

作者信息

Uraoka Toshio, Saito Yutaka, Yamamoto Kazuhide, Fujii Takahiro

机构信息

Department of Gastroenterology and Hepatology, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

出版信息

Drug Des Devel Ther. 2009 Feb 6;2:131-8. doi: 10.2147/dddt.s3219.

Abstract

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) have provided new alternatives for minimally invasive treatment of gastrointestinal adenomas and early-stage cancers that involve a minimum risk of lymph-node metastasis. The use of submucosal injections is essential to the success of these endoscopic resection techniques. The "ideal" submucosal injection solution should provide a sufficiently high submucosal fluid cushion for safe and effective EMRs and ESDs while also preserving lesion tissue for accurate histopathological assessment. In the past, normal saline (NS) solution was commonly used for this purpose, but it is difficult to achieve the proper submucosal elevation and maintain the desired height with NS. Therefore, other safe and effective facilitative submucosal injection solutions have been developed that also take into account relevant cost-benefit considerations. This review examines recent advances in the development of effective submucosal injection solutions for use during endoscopic resections.

摘要

内镜黏膜切除术(EMR)和内镜黏膜下剥离术(ESD)为胃肠道腺瘤和早期癌症的微创治疗提供了新的选择,这些疾病发生淋巴结转移的风险最低。黏膜下注射的应用对于这些内镜切除技术的成功至关重要。“理想的”黏膜下注射溶液应提供足够高的黏膜下液垫,以实现安全有效的EMR和ESD,同时还应保留病变组织以进行准确的组织病理学评估。过去,生理盐水(NS)溶液常用于此目的,但使用NS很难实现适当的黏膜下隆起并维持所需的高度。因此,人们开发了其他安全有效的辅助性黏膜下注射溶液,这些溶液也考虑了相关的成本效益因素。本综述探讨了内镜切除术中有效黏膜下注射溶液开发的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807c/2761197/19c7feba2040/dddt-2-131f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验